![David R. Seaton](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
David R.
Seaton served as the Acting CEO, Chief Financial Officer & Secretary at MEI Pharma, Inc. from 2009 to 2010.
Prior to that, he was the Chief Financial Officer at Kazia Therapeutics Ltd. from 1999 to 2010.
He also served as the Chief Financial Officer & Secretary at Glycotex, Inc. Mr. Seaton received his undergraduate and graduate degrees from The University of New South Wales.
Anciens postes connus de David R. Seaton
| Sociétés | Poste | Fin |
|---|---|---|
| KAZIA THERAPEUTICS LIMITED | Directeur Financier/CFO | 18/06/2010 |
| LITE STRATEGY, INC. | Directeur Financier/CFO | 21/06/2010 |
Glycotex, Inc.
 Glycotex, Inc. BiotechnologyHealth Technology Researches and develops drugs | Directeur Financier/CFO | - |
Formation de David R. Seaton
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
8
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Kazia Therapeutics Ltd.
 Kazia Therapeutics Ltd. BiotechnologyHealth Technology Engages in the business of pharmaceutical research and development | Health Technology |
Glycotex, Inc.
Glycotex, Inc. BiotechnologyHealth Technology Researches and develops drugs | Health Technology |
MEI Pharma, Inc.
 MEI Pharma, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals products | Health Technology |
The University of New South Wales
 The University of New South Wales Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
